Company News & Information

TalkMarkets Newswire is a premier service which disseminates and distributes critical news, press releases and information about a variety of companies. This information is seen by readers not only on TalkMarkets, but also goes out to our distribution partners which include such leading ... more

ALL CONTRIBUTIONS

American Resources Corporation Unveils Rare Earth Element Wholly Owned Subsidiary, American Rare Earth LLC
American Resources Corporation, a supplier of raw materials to the rapidly growing global infrastructure marketplace, today unveiled its wholly owned subsidiary, American Rare Earth LLC ("American Rare Earth").
Read
Sonnet BioTherapeutics Receives $10.5 Million From Exercise Of Series A Warrants
Sonnet Bio announced today that, as part of the previously announced warrant exchange agreement, all 3,300,066 Series A Warrants have been exercised at a price of $3.19 per share. Gross proceeds to the Company were $10.5 Million.
Read
Protalix BioTherapeutics Announces FDA Acceptance Of BLA For The Treatment Of Fabry Disease And Grants Priority Review
Priority Review is granted to therapies that the FDA determines have the potential to provide significant improvements in the treatment, diagnosis or prevention of serious conditions.
Read
VistaGen Therapeutics Announces Positive Meeting With FDA Regarding Pivotal Phase 3 Study Of PH94B For Acute Treatment Of Anxiety In Patients With Social Anxiety Disorder
VistaGen and the FDA reached consensus on key aspects of a unique initial pivotal Phase 3 clinical trial of PH94B involving a single-event, laboratory-simulated public speaking challenge in adult patients with SAD.
Read
CytoDyn Files Application With Nasdaq For Uplist
CytoDyn Inc., announced today it recently filed a comprehensive listing application package with The Nasdaq Stock Market to request an uplisting of the Company’s common stock.
Read
Vaccinex Provides Update Of Potentially Pivotal SIGNAL Clinical Trial In Huntington’s Disease
Vaccinex, Inc. is a clinical-stage immunotherapy company engaged in the discovery and development of targeted biotherapeutics to treat serious diseases and conditions with unmet medical needs.
Read

STOCKS I FOLLOW

TWEETS

PERSONAL BLOG

Latest Posts

Work Experience

Education

Publications